• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Chronic granulocytic leukemia: reassessment of morphologic and cytogenetic characteristics in Ph1-positive and Ph1-negative cases.

作者信息

Crisan D, Mattson J C, al-Saadi A

机构信息

Department of Clinical Pathology, William Beaumont Hospital, Royal Oak, MI 48072.

出版信息

Eur J Haematol. 1991 Feb;46(2):77-84. doi: 10.1111/j.1600-0609.1991.tb00526.x.

DOI:10.1111/j.1600-0609.1991.tb00526.x
PMID:1995326
Abstract

33 cases of chronic granulocytic leukemia (CGL) were reassessed to determine if, by strict morphologic criteria. Philadelphia chromosome (Ph1)-negative CGL exists as a diagnostic entity and if Ph1-positive CGL could be distinguished from Ph1-negative CGL. Cases were reassessed using published criteria and, of 11 Ph1-negative cases, only 4 could be reclassified as myelodysplastic syndromes or undifferentiated chronic myeloproliferative disorder. Of the morphologic parameters evaluated, peripheral blood basophilia and bicytopenia proved to be good discriminators between Ph1-positive and Ph1-negative cases. As a group, Ph1-negative cases were more heterogeneous and tended to have lower hemoglobin, WBC, platelet count and absolute eosinophilia. Chromosomal abnormalities other than Ph1 were seen only in the Ph1-positive cases. Based on these findings, we conclude that Ph1-negative CGL constitutes a heterogeneous group, a subgroup of which is morphologically identical with the Ph1-positive CGL. The parameters that best discriminate between Ph1-positive and Ph1-negative cases are peripheral blood absolute basophilia and bicytopenia.

摘要

相似文献

1
Chronic granulocytic leukemia: reassessment of morphologic and cytogenetic characteristics in Ph1-positive and Ph1-negative cases.
Eur J Haematol. 1991 Feb;46(2):77-84. doi: 10.1111/j.1600-0609.1991.tb00526.x.
2
Ph1-negative chronic granulocytic leukemia: a nonentity.
Am J Clin Pathol. 1986 Feb;85(2):186-93. doi: 10.1093/ajcp/85.2.186.
3
Philadelphia chromosome-negative chronic myelogenous leukaemia: a morphological reassessment.费城染色体阴性慢性粒细胞白血病:形态学重新评估
Br J Haematol. 1985 Jul;60(3):457-67. doi: 10.1111/j.1365-2141.1985.tb07443.x.
4
Evidence from molecular genetic and cytogenetic analyses that bone marrow histopathology is reliable in the diagnosis of chronic myeloproliferative disorders.
Virchows Arch B Cell Pathol Incl Mol Pathol. 1993;63(4):199-204. doi: 10.1007/BF02899262.
5
[An elderly patient with Ph1-positive chronic myelomonocytic leukemia].[一名伴有费城染色体阳性的慢性粒单核细胞白血病老年患者]
Nihon Ronen Igakkai Zasshi. 1996 Sep;33(9):702-6. doi: 10.3143/geriatrics.33.702.
6
Reverse transcriptase-polymerase chain reaction for bcr/abl fusion in chronic myelogenous leukemia.用于慢性粒细胞白血病中bcr/abl融合基因检测的逆转录聚合酶链反应
Am J Clin Pathol. 1996 Jun;105(6):756-60. doi: 10.1093/ajcp/105.6.756.
7
[Differential diagnosis of chronic myeloid leukemia and the related disorders].[慢性髓性白血病及相关疾病的鉴别诊断]
Nihon Rinsho. 2001 Dec;59(12):2358-62.
8
Difference of cell lineage expression of haematopoietic progenitor cells in Philadelphia-positive acute lymphoblastic leukaemia and chronic myelogenous leukaemia.费城染色体阳性急性淋巴细胞白血病与慢性粒细胞白血病中造血祖细胞的细胞谱系表达差异
Br J Haematol. 1988 Sep;70(1):21-6. doi: 10.1111/j.1365-2141.1988.tb02428.x.
9
The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia.外周血、骨髓穿刺液,尤其是骨髓活检切片在鉴别不典型慢性髓细胞白血病与慢性粒细胞白血病及慢性粒单核细胞白血病中的作用。
Eur J Haematol. 2009 Oct;83(4):292-301. doi: 10.1111/j.1600-0609.2009.01283.x. Epub 2009 Jun 2.
10
Clinical manifestations of chronic granulocytic leukemia.慢性粒细胞白血病的临床表现。
Semin Oncol. 1995 Aug;22(4):380-95.